Prism AI
Prism AI offers an AI-first clinical multi-omic data management and analytics platform designed for biotech companies and health systems. Their platform aims to help organizations unlock the potential of their data to develop the next generation of drugs and biomarkers. They focus on accelerating effective cures for devastating diseases. The company is supported by leading technology and innovation partners.
Prism AI
Prism AI offers an AI-first clinical multi-omic data management and analytics platform designed for biotech companies and health systems. Their platform aims to help organizations unlock the potential of their data to develop the next generation of drugs and biomarkers. They focus on accelerating effective cures for devastating diseases. The company is supported by leading technology and innovation partners.
TL;DR
Founded: 2024
Headquarters: Salt Lake City, Utah, United States
Industry: Biotechnology
Focus: AI platform for drug development and biomarker discovery
Seed investor: Vela Partners
Company Overview
Problem Domain
Drug development and biomarker discovery using multi-omic clinical data
Founded
2024
Industry
Biotechnology
Tech Stack
Funding Track Record
Listed as a Seed round on public profiles; amount obfuscated in available data.
Investor Signal
“Backed by Vela Partners (Seed)”